Filtered By:
Source: Stroke
Condition: Hemorrhagic Stroke
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 995 results found since Jan 2013.
Automated Software System to Promote Anticoagulation and Reduce Stroke Risk Brief Report
Conclusions—No significant change in OAC prescribing occurred. A greater rate of diagnosis of transient ischemic attack (possibly because of improved detection or overdiagnosis) was associated with a reduction (of borderline significance) in stroke and hemorrhage over 12 months.Clinical Trial Registration—URL: http://www.isrctn.com. Unique Identifier: ISRCTN55722437.
Source: Stroke - February 26, 2017 Category: Neurology Authors: Tim A. Holt, Andrew Dalton, Tom Marshall, Matthew Fay, Nadeem Qureshi, Susan Kirkpatrick, Jenny Hislop, Daniel Lasserson, Karen Kearley, Jill Mollison, Ly-Mee Yu, F.D. Richard Hobbs, David Fitzmaurice Tags: Atrial Fibrillation, Anticoagulants, Health Services, Ischemic Stroke Brief Reports Source Type: research
Proportional Motor Recovery After Stroke Brief Report
Conclusions—Recovery of motor impairment in patients with intact CST is proportional to initial impairment and unaffected by previous stroke, type of stroke, or upper-limb therapy dose. Novel interventions that interact with the neurobiological mechanisms of recovery are needed. The generalizability of proportional recovery is such that patients with intracerebral hemorrhage and previous stroke may usefully be included in interventional rehabilitation trials.Clinical Trial Registration—URL: http://www.anzctr.org.au. Unique identifier: ANZCTR12611000755932.
Source: Stroke - February 26, 2017 Category: Neurology Authors: Cathy M. Stinear, Winston D. Byblow, Suzanne J. Ackerley, Marie-Claire Smith, Victor M. Borges, P. Alan Barber Tags: Prognosis, Intracranial Hemorrhage, Ischemic Stroke Brief Reports Source Type: research
Disparities in the Use of Seizure Medications After Intracerebral Hemorrhage Brief Report
Background and Purpose—We investigated potential disparities in the use of prophylactic seizure medications in patients with intracerebral hemorrhage.Methods—Review of multicenter electronic health record (EHR) data with simultaneous prospective data recording. EHR data were retrieved from HealthLNK, a multicenter EHR repository in Chicago, Illinois, from 2006 to 2012 (multicenter cohort). Additional data were prospectively coded (single-center cohort) from 2007 through 2015.Results—The multicenter cohort comprised 3422 patients from 4 HealthLNK centers. Use of levetiracetam varied by race/ethnicity (P=0.0000008), wi...
Source: Stroke - February 26, 2017 Category: Neurology Authors: Andrew M. Naidech, Paloma Toledo, Shyam Prabhakaran, Jane L. Holl Tags: Health Services, Intracranial Hemorrhage Brief Reports Source Type: research
Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association AHA/ASA Scientific Statement
Two decades of epidemiological research shows that silent cerebrovascular disease is common and is associated with future risk for stroke and dementia. It is the most common incidental finding on brain scans. To summarize evidence on the diagnosis and management of silent cerebrovascular disease to prevent stroke, the Stroke Council of the American Heart Association convened a writing committee to evaluate existing evidence, to discuss clinical considerations, and to offer suggestions for future research on stroke prevention in patients with 3 cardinal manifestations of silent cerebrovascular disease: silent brain infarcts...
Source: Stroke - January 22, 2017 Category: Neurology Authors: Eric E. Smith, Gustavo Saposnik, Geert Jan Biessels, Fergus N. Doubal, Myriam Fornage, Philip B. Gorelick, Steven M. Greenberg, Randall T. Higashida, Scott E. Kasner, Sudha Seshadri Tags: Statements and Guidelines AHA/ASA Scientific Statement Source Type: research
Adherence to a Healthy Nordic Diet and Risk of Stroke Clinical Sciences
Conclusions—Our findings suggest that a healthy Nordic diet may be recommended for the prevention of stroke.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Camilla Plambeck Hansen, Kim Overvad, Cecilie Kyro, Anȷa Olsen, Anne Tȷonneland, Soren Paaske Johnsen, Marianne Uhre Jakobsen, Christina Catherine Dahm Tags: Cardiovascular Disease, Diet and Nutrition, Epidemiology, Intracranial Hemorrhage, Ischemic Stroke Original Contributions Source Type: research
Strokes Associated With Pregnancy and Puerperium Clinical Sciences
Conclusions—The incidence of pregnancy-associated stroke in Japan did not seem higher than that in other Asian and Western countries. The proportion of hemorrhagic stroke among Japanese women was much higher than that in white women. Preexisting cerebrovascular diseases and reversible cerebral vasoconstriction syndrome play a key role in hemorrhagic and ischemic stroke, respectively.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Kazumichi Yoshida, Jun C. Takahashi, Yohei Takenobu, Norihiro Suzuki, Akira Ogawa, Susumu Miyamoto Tags: Epidemiology, Pregnancy, Cerebrovascular Disease/Stroke Original Contributions Source Type: research
Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation Clinical Sciences
Conclusions—This nationwide observational study suggests that anticoagulant treatment may be initiated 7 to 8 weeks after ICH in patients with atrial fibrillation to optimize the benefit from treatment and minimize risk.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Johanna Pennlert, Rosanna Overholser, Kjell Asplund, Bo Carlberg, Bart Van Rompaye, Per-Gunnar Wiklund, Marie Eriksson Tags: Atrial Fibrillation, Anticoagulants, Treatment, Intracranial Hemorrhage, Ischemic Stroke Original Contributions Source Type: research
NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study) Clinical Sciences
Conclusions—CEST is safe among unselected ischemic stroke patients with or without a visible occlusion on computed tomography angiography and with varying grades of clinical severity. There was, however, statistically no significant clinical effect of sonothrombolysis in this prematurely stopped trial.Clinical Trial Registration—URL: http://www.clinicaltrials.gov. Unique identifier: NCT01949961.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Aliona Nacu, Christopher E. Kvistad, Halvor Naess, Halvor Oygarden, Nicola Logallo, Jorg Assmus, Ulrike Waȷe–Andreassen, Kathinka D. Kurz, Gesche Neckelmann, Lars Thomassen Tags: Clinical Studies, Ischemia, Cerebrovascular Disease/Stroke, Ischemic Stroke Original Contributions Source Type: research
Is Unexplained Early Neurological Deterioration After Intravenous Thrombolysis Associated With Thrombus Extension? Clinical Sciences
Conclusions—In this study, unexplained END occurring after thrombolysis was independently associated with susceptibility vessel sign extension, suggesting in situ thrombus extension or re-embolization. These findings strengthen the need to further investigate early post-thrombolysis administration of antithrombotics to reduce the risk of this ominous clinical event.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Pierre Seners, Robert Hurford, Marie Tisserand, Guillaume Turc, Laurence Legrand, Olivier Naggara, Jean-Louis Mas, Catherine Oppenheim, Jean-Claude Baron Tags: Magnetic Resonance Imaging (MRI), Ischemic Stroke Original Contributions Source Type: research
Pioglitazone for Secondary Stroke Prevention Clinical Sciences
Conclusions—Pioglitazone reduces recurrent stroke and major vascular events in ischemic stroke patients with insulin resistance, prediabetes, and diabetes mellitus.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Meng Lee, Jeffrey L. Saver, Hung-Wei Liao, Chun-Hsien Lin, Bruce Ovbiagele Tags: Cardiovascular Disease, Diabetes, Type 2, Secondary Prevention, Meta Analysis, Cerebrovascular Disease/Stroke Original Contributions Source Type: research
12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke Basic Sciences
Conclusions—In addition to its benefits in infarct size reduction, 12/15-LOX inhibition also may independently reduce HT in warfarin-treated mice. ML351 should be further evaluated as stroke treatment in anticoagulated patients suffering a stroke, either alone or in conjunction with tissue-type plasminogen activator.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Yu Liu, Yi Zheng, Hulya Karatas, Xiaoying Wang, Christian Foerch, Eng H. Lo, Klaus van Leyen Tags: Blood-Brain Barrier, Ischemic Stroke, Neuroprotectants Original Contributions Source Type: research
Valproate Reduces Delayed Brain Injury in a Rat Model of Subarachnoid Hemorrhage Basic Sciences
Conclusions—In our rat SAH model, valproate treatment significantly reduced brain lesion growth after KCl application. Future studies are needed to confirm that this protective effect is based on SD inhibition.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Arend M. Hamming, Annette van der Toorn, Umesh S. Rudrapatna, Lisha Ma, Hine J.A. van Os, Michel D. Ferrari, Arn M.J.M. van den Maagdenberg, Erik van Zwet, Katherine Poinsatte, Ann M. Stowe, Rick M. Dijkhuizen, Marieke J.H. Wermer Tags: Animal Models of Human Disease, Magnetic Resonance Imaging (MRI), Pharmacology, Cerebral Aneurysm, Neuroprotectants Original Contributions Source Type: research
Discharge Disposition After Stroke in Patients With Liver Disease Brief Report
Conclusions—Liver disease was associated with worse hospital discharge disposition and in-hospital mortality after stroke, suggesting worse functional outcomes.
Source: Stroke - January 22, 2017 Category: Neurology Authors: Neal S. Parikh, Alexander E. Merkler, Yecheskel Schneider, Babak B. Navi, Hooman Kamel Tags: Risk Factors, Mortality/Survival, Cerebrovascular Disease/Stroke, Intracranial Hemorrhage, Ischemic Stroke Brief Reports Source Type: research
Lacunar Infarcts and Intracerebral Hemorrhage Differences Brief Report
Background and Purpose—Lacunar stroke (LS) and intracerebral hemorrhage (ICH) are 2 diverse manifestations of small vessel disease. What predisposes some patients to ischemic stroke and others to hemorrhage is not well understood.Methods—We performed a nested case–control study within the FHS (Framingham Heart Study) comparing people with incident ICH and lacunar ischemic stroke, to age- and sex-matched controls for baseline prevalence and levels of cardiovascular risk factors.Results—We identified 118 LS (mean age 74 years, 51% male) and 108 ICH (75 years, 46% male) events. Hypertension, diabetes mellitus, smoking...
Source: Stroke - January 22, 2017 Category: Neurology Authors: Vasileios-Arsenios Lioutas, Alexa Beiser, Jayandra Himali, Hugo Aparicio, Jose Rafael Romero, Charles DeCarli, Sudha Seshadri Tags: Obesity, Risk Factors, Cerebrovascular Disease/Stroke, Intracranial Hemorrhage, Ischemic Stroke Brief Reports Source Type: research
Letter by Jennings Regarding Article, “Stroke Risk and Mortality in Patients With Ventricular Assist Devices” Letter to the Editor
Source: Stroke - December 22, 2016 Category: Neurology Authors: Douglas L. Jennings Tags: Cerebrovascular Disease/Stroke, Intracranial Hemorrhage, Ischemic Stroke Letters to the Editor Source Type: research
